One concern about MUC16 as a therapeutic/imaging target is that the cleavage and shedding of the extracellular domain of MUC16 in serum or in the peritoneal fluid of patients may reduce or inhibit the accumulation of M16Ab in the tumor and obscure the visualization of small lesions [40]. The gene discussed is MUC16; the disease is neoplasm.